UNSPSC 51384102: Metbufen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H16O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8AE88M5N5V, chemically known as propionic acid, 3-(4-biphenylylcarbonyl)-2-methyl- but generally known as metbufen, which bears US NIH Compound Identifier 68823. European Medicines Agency schedules Metbufen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08821MIG.

UNSPSC 51384102 Metbufen is a Commodity code that covers pharmaceutical products, though the recent state and local activity under this code shows a significant mismatch with the nominal classification. Seminole County, Florida posted an IFB in June 2026 seeking to procure naloxone and safe drug deactivation systems—emergency response and harm-reduction supplies rather than the specific pharmaceutical indicated by the code name. The solicitation calls for 1,900 units of naloxone and 800 deactivation systems annually, with quarterly deliveries to the county's community health building and contract terms of two years plus one optional renewal year. Vendors must submit bids electronically, include all shipping and delivery costs in pricing, maintain workers' compensation and commercial general liability insurance, comply with E-Verify employment verification, and certify drug-free workplace status. The procurement introduced potential FEMA funding, which triggers compliance with the Clean Air Act and Federal Water Pollution Control Act, and included a three-month probationary period allowing termination without cause.

The code shows minimal recent state and local procurement activity, with only this single recent opportunity visible. Seminole County, Florida is the identified buyer. The response deadline stated in the opportunity record is July 26, 2023, which appears to reflect historical posting dates rather than current procurement cycles; the opportunity was posted in June 2026 according to the metadata. Given the limited recent activity and the disconnect between the code's pharmaceutical classification and the actual goods being solicited, the code does not appear to represent a meaningful category for state and local procurement targeting at this time.